These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

238 related items for PubMed ID: 1659573

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. TGF-β2 promotes RPE cell invasion into a collagen gel by mediating urokinase-type plasminogen activator (uPA) expression.
    Sugioka K, Kodama A, Okada K, Iwata M, Yoshida K, Kusaka S, Matsumoto C, Kaji H, Shimomura Y.
    Exp Eye Res; 2013 Oct; 115():13-21. PubMed ID: 23810810
    [Abstract] [Full Text] [Related]

  • 25. Increased invasion of neuroglioma cells transfected with urokinase plasminogen activator receptor cDNA.
    Mohanam S, Chintala SK, Mohan PM, Sawaya R, Lagos GK, Gokaslan ZL, Kouraklis GP, Rao JS.
    Int J Oncol; 1998 Dec; 13(6):1285-90. PubMed ID: 9824646
    [Abstract] [Full Text] [Related]

  • 26. Role of urokinase plasminogen activator receptor in thrombospondin 1-mediated tumor cell invasion.
    Albo D, Berger DH, Rothman VL, Tuszynski GP.
    J Surg Res; 1999 Apr; 82(2):331-8. PubMed ID: 10090848
    [Abstract] [Full Text] [Related]

  • 27. Modulation of invasive properties of human glioblastoma cells stably expressing amino-terminal fragment of urokinase-type plasminogen activator.
    Mohanam S, Chandrasekar N, Yanamandra N, Khawar S, Mirza F, Dinh DH, Olivero WC, Rao JS.
    Oncogene; 2002 Nov 07; 21(51):7824-30. PubMed ID: 12420219
    [Abstract] [Full Text] [Related]

  • 28. Characterization of the cellular binding site for the urokinase-type plasminogen activator.
    Estreicher A, Wohlwend A, Belin D, Schleuning WD, Vassalli JD.
    J Biol Chem; 1989 Jan 15; 264(2):1180-9. PubMed ID: 2536017
    [Abstract] [Full Text] [Related]

  • 29. A high-affinity receptor for urokinase plasminogen activator on human keratinocytes: characterization and potential modulation during migration.
    McNeill H, Jensen PJ.
    Cell Regul; 1990 Oct 15; 1(11):843-52. PubMed ID: 1965151
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Targeting of urokinase plasminogen activator receptor in human pancreatic carcinoma cells inhibits c-Met- and insulin-like growth factor-I receptor-mediated migration and invasion and orthotopic tumor growth in mice.
    Bauer TW, Liu W, Fan F, Camp ER, Yang A, Somcio RJ, Bucana CD, Callahan J, Parry GC, Evans DB, Boyd DD, Mazar AP, Ellis LM.
    Cancer Res; 2005 Sep 01; 65(17):7775-81. PubMed ID: 16140945
    [Abstract] [Full Text] [Related]

  • 35. Invasion by esophageal cancer cells: functional contribution of the urokinase plasminogen activation system, and inhibition by antisense oligonucleotides to urokinase or urokinase receptor.
    Morrissey D, O'Connell J, Lynch D, O'Sullivan GC, Shanahan F, Collins JK.
    Clin Exp Metastasis; 1999 Feb 01; 17(1):77-85. PubMed ID: 10390151
    [Abstract] [Full Text] [Related]

  • 36. Invasion of connective tissue by human carcinoma cell lines: requirement for urokinase, urokinase receptor, and interstitial collagenase.
    Ossowski L.
    Cancer Res; 1992 Dec 15; 52(24):6754-60. PubMed ID: 1333882
    [Abstract] [Full Text] [Related]

  • 37. Cloning and expression of the receptor for human urokinase plasminogen activator, a central molecule in cell surface, plasmin dependent proteolysis.
    Roldan AL, Cubellis MV, Masucci MT, Behrendt N, Lund LR, Danø K, Appella E, Blasi F.
    EMBO J; 1990 Feb 15; 9(2):467-74. PubMed ID: 1689240
    [Abstract] [Full Text] [Related]

  • 38. Expression of urokinase-type plasminogen activator/urokinase-type plasminogen activator receptor and maspin in oral squamous cell carcinoma: Association with mode of invasion and clinicopathological factors.
    Yoshizawa K, Nozaki S, Kitahara H, Kato K, Noguchi N, Kawashiri S, Yamamoto E.
    Oncol Rep; 2011 Dec 15; 26(6):1555-60. PubMed ID: 21833477
    [Abstract] [Full Text] [Related]

  • 39. Subcellular distribution of urokinase and urokinase receptor in human neutrophils determined by immunoelectron microscopy.
    Pedersen TL, Plesner T, Horn T, Høyer-Hansen G, Sørensen S, Hansen NE.
    Ultrastruct Pathol; 2000 Dec 15; 24(3):175-82. PubMed ID: 10914429
    [Abstract] [Full Text] [Related]

  • 40. Murine monoclonal antibodies against murine uPA receptor produced in gene-deficient mice: inhibitory effects on receptor-mediated uPA activity in vitro and in vivo.
    Pass J, Jögi A, Lund IK, Rønø B, Rasch MG, Gårdsvoll H, Lund LR, Ploug M, Rømer J, Danø K, Høyer-Hansen G.
    Thromb Haemost; 2007 Jun 15; 97(6):1013-22. PubMed ID: 17549305
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 12.